Literature DB >> 28074248

Pregnancy-associated osteoporosis: a case-control study.

P Hadji1,2, J Boekhoff3, M Hahn3, L Hellmeyer4, O Hars5, I Kyvernitakis6,7.   

Abstract

The etiology and underlying mechanisms of pregnancy-associated osteoporosis (PAO) are still unknown, since no systematic analyses exist. Our results indicate that PAO is a heterogeneous, rare but severe disease including a substantial number of fractures with a significant delay from first symptom to diagnose.
INTRODUCTION: Pregnancy-associated osteoporosis (PAO) is a rare but severe type of premenopausal osteoporosis. Most common symptom includes acute lower back pain due to vertebral fracture predominantly occurring in the last trimester of pregnancy or immediately postpartum. The exact underlining mechanisms and risk factors of PAO are still unknown, and up to date, there are no published systematic analyses.
METHODS: We identified 102 PAO patients and matched them with 102 healthy controls according to age, region, and gravidity to evaluate risk factors in a large and homogenous population of women.
RESULTS: The baseline characteristics and anthropometric data of the two study groups were similar. Eighty-eight percent of the patients with PAO suffered from one or more fractures with a mean of 3.3 fractures per patient. The most common fracture site was the thoracolumbar spine, whereas 29, 37, 48, and 35% of the patients reported fractures at TH11, TH12, L1, and L2, respectively. PAO patients suffered more frequently from excessive dental problems in childhood (p < 0.001). The control group performed significantly more frequently sports both before (p < 0.002) and after puberty (p < 0.01). Compared to the controls, the patients with PAO reported twice as often severe diseases during pregnancy (p < 0.029). Hereby, the frequency of immobilization was twice as often in the PAO group compared to that in the control group (p < 0.005).
CONCLUSIONS: Our results indicate that PAO is a heterogeneous, rare but severe disease including a substantial number of fractures with a significant delay from first symptom to diagnose. Increased awareness is warranted to immediately start effective treatment.

Entities:  

Keywords:  Fracture risk; Pregancy associated osteoporosis; Risk factors

Mesh:

Year:  2017        PMID: 28074248     DOI: 10.1007/s00198-016-3897-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  24 in total

Review 1.  The role of vitamin D in pregnancy and lactation: insights from animal models and clinical studies.

Authors:  Christopher S Kovacs
Journal:  Annu Rev Nutr       Date:  2012-04-05       Impact factor: 11.848

2.  [Diagnosing osteoporosis: what is new in the 2014 DVO guideline?].

Authors:  Johannes Pfeilschifter
Journal:  Dtsch Med Wochenschr       Date:  2015-11-04       Impact factor: 0.628

Review 3.  Presentation and management of osteoporosis presenting in association with pregnancy or lactation.

Authors:  C S Kovacs; S H Ralston
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

Review 4.  Pathophysiology of bone loss in disuse osteoporosis.

Authors:  Christian Alexandre; Laurence Vico
Journal:  Joint Bone Spine       Date:  2011-06-12       Impact factor: 4.929

5.  Influence of number of deliveries and total breast-feeding time on bone mineral density in premenopausal and young postmenopausal women.

Authors:  Gloria Tsvetov; Sigal Levy; Carlos Benbassat; Ilana Shraga-Slutzky; Dania Hirsch
Journal:  Maturitas       Date:  2013-11-27       Impact factor: 4.342

6.  Treatment with teriparatide in a patient with pregnancy-associated osteoporosis.

Authors:  Lars Hellmeyer; Jelena Boekhoff; Peyman Hadji
Journal:  Gynecol Endocrinol       Date:  2010-10       Impact factor: 2.260

7.  Osteoporosis of pregnancy.

Authors:  R Smith; J C Stevenson; C G Winearls; C G Woods; B P Wordsworth
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

8.  Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin.

Authors:  T C Dahlman
Journal:  Am J Obstet Gynecol       Date:  1993-04       Impact factor: 8.661

9.  Pregnancy-associated osteoporosis.

Authors:  R Smith; N A Athanasou; S J Ostlere; S E Vipond
Journal:  QJM       Date:  1995-12

10.  The history of osteoporosis: why do Egyptian mummies have porotic bones?

Authors:  P J O Stride; N Patel; D Kingston
Journal:  J R Coll Physicians Edinb       Date:  2013
View more
  10 in total

1.  Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life.

Authors:  Martin Gehlen; Ana Doina Lazarescu; Christian Hinz; Michael Schwarz-Eywill; Michael Pfeifer; Subathira Balasingam; Anna Maier
Journal:  Clin Rheumatol       Date:  2019-08-29       Impact factor: 2.980

2.  Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.

Authors:  S Butscheidt; A Delsmann; T Rolvien; F Barvencik; M Al-Bughaili; S Mundlos; T Schinke; M Amling; U Kornak; R Oheim
Journal:  Osteoporos Int       Date:  2018-03-29       Impact factor: 4.507

3.  Fractures within 2 years of an obstetric hospitalization: analysis of nationwide administrative data in Japan.

Authors:  Mikayo Toba; Masakazu Terauchi; Mutsuko Moriwaki; Satoshi Obayashi; Naoyuki Miyasaka; Kiyohide Fushimi
Journal:  J Bone Miner Metab       Date:  2022-06-12       Impact factor: 2.976

4.  A case of pregnancy and lactation associated osteoporosis in the third pregnancy; robust response to teriparatide despite delayed administration.

Authors:  Ethem Turgay Cerit; Mahinur Cerit
Journal:  Bone Rep       Date:  2020-08-13

5.  Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.

Authors:  I Kyvernitakis; T C Reuter; L Hellmeyer; O Hars; P Hadji
Journal:  Osteoporos Int       Date:  2017-09-30       Impact factor: 4.507

6.  Intertrochanteric fracture in pregnancy- and lactation-associated osteoporosis.

Authors:  Zeng Jun Jie; Guo Ai; Wang Baojun; Zhang Liang
Journal:  J Int Med Res       Date:  2019-07-01       Impact factor: 1.671

7.  Case report: Early-onset osteoporosis in a patient carrying a novel heterozygous variant of the WNT1 gene.

Authors:  Maria Cristina Campopiano; Antonella Fogli; Angela Michelucci; Laura Mazoni; Antonella Longo; Simona Borsari; Elena Pardi; Elena Benelli; Chiara Sardella; Laura Pierotti; Elisa Dinoi; Claudio Marcocci; Filomena Cetani
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

8.  Effect of Teriparatide on Subsequent Fracture and Bone Mineral Density in 47 Women with Pregnancy- and Lactation-associated Osteoporosis and Vertebral Fractures.

Authors:  Peyman Hadji; Niki Mouzakiti; Ioannis Kyvernitakis
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-06-03       Impact factor: 2.754

9.  Barton Fracture of the Distal Radius in Pregnancy and Lactation-Associated Osteoporosis: A Case Report and Literature Review.

Authors:  Gang Wang; Xiaodong Bai
Journal:  Int J Gen Med       Date:  2020-11-06

10.  Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis.

Authors:  U Stumpf; M Kraus; P Hadji
Journal:  Osteoporos Int       Date:  2021-05-26       Impact factor: 4.507

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.